Hospital
Emanate Health Medical Center
Emanate Health Medical Center was paid $11.22M by Medicaid between Jan 2018 and Dec 2024, across 288 billing codes. Its largest line is 0450, Emergency room services — 26% of everything it billed.
33Billing provider infoEMANATE HEALTH MEDICAL CENTER
COVINA, CA 91723
COVINA, CA 91723
33aNPI1982629440assigned 07/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.22M
24GClaims816,279
24DCodes billed288
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#168 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 114,859 | $1.32M | |
| 2019 | 116,408 | $1.51M | |
| 2020 | 92,699 | $1.19M | |
| 2021 | 103,377 | $1.46M | |
| 2022 | 119,242 | $1.93M | |
| 2023 | 142,600 | $2.14M | |
| 2024incomplete | 127,094 | $1.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 26% | 88,030 | 77,341 | $2.90M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.5% | 6,772 | 6,590 | $509K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.9% | 6,339 | 6,161 | $443K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.3% | 22,969 | 20,759 | $376K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 2,374 | 2,314 | $337K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.8% | 2,164 | 2,002 | $318K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 8,906 | 8,274 | $300K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.7% | 20,114 | 18,202 | $299K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.6% | 6,448 | 5,521 | $290K |
| 99199 | Unlisted special service, procedure or report | 2.3% | 9,442 | 8,190 | $263K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.1% | 3,963 | 3,671 | $238K |
| 80053 | Comprehensive metabolic panel | 2.0% | 42,343 | 38,668 | $226K |
276 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 6,391 | $183K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 3,934 | $179K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 48,193 | $176K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 19,793 | $170K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 4,346 | $152K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.2% | 9,231 | $137K |
| 0112 | 1.2% | 190 | $133K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 3,620 | $125K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 7,250 | $123K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.1% | 2,997 | $118K |
| J3490 | Unclassified drugs | <1% | 30,204 | $106K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 870 | $105K |
| 99284 | Emergency room visit (serious) | <1% | 1,140 | $94K |
| 0270 | <1% | 27,067 | $92K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,422 | $91K |
| 93971 | <1% | 1,353 | $88K | |
| 0510 | <1% | 4,951 | $85K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 907 | $79K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,585 | $78K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,276 | $75K |
| 84484 | <1% | 13,924 | $75K | |
| Z7502 | <1% | 1,943 | $72K | |
| 0762 | <1% | 2,529 | $70K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 387 | $64K |
| 76830 | Ultrasound, transvaginal | <1% | 1,694 | $62K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13,919 | $62K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 469 | $60K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,597 | $57K |
| 0360 | <1% | 2,152 | $55K | |
| 0250 | <1% | 19,428 | $53K | |
| 83690 | <1% | 12,809 | $52K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,651 | $49K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,383 | $48K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,932 | $47K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,683 | $45K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,163 | $44K |
| 83880 | <1% | 2,931 | $44K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,056 | $43K |
| 82803 | <1% | 3,981 | $42K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,454 | $42K |
| 0301 | <1% | 2,784 | $42K | |
| 0160 | <1% | 1,701 | $41K | |
| 0171 | Inj, epinephrine (belcher) | <1% | 339 | $40K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,852 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,100 | $40K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,637 | $37K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,582 | $35K |
| 87040 | <1% | 3,832 | $35K | |
| 90715 | <1% | 1,481 | $34K | |
| 99221 | <1% | 993 | $30K | |
| 81001 | <1% | 19,121 | $30K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,188 | $29K |
| 73564 | <1% | 1,681 | $28K | |
| 93970 | <1% | 302 | $28K | |
| 73630 | <1% | 1,963 | $28K | |
| 81025 | <1% | 8,807 | $26K | |
| 73610 | <1% | 1,793 | $25K | |
| 73030 | <1% | 1,551 | $22K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,636 | $20K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 810 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,601 | $20K |
| 73130 | <1% | 1,208 | $19K | |
| 0637 | <1% | 5,154 | $19K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,759 | $16K |
| 83735 | <1% | 4,072 | $15K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,270 | $15K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,742 | $14K |
| 81003 | <1% | 11,730 | $14K | |
| 85730 | <1% | 4,530 | $14K | |
| 83605 | <1% | 2,104 | $13K | |
| 85610 | <1% | 6,078 | $13K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 143 | $13K |
| 84702 | <1% | 2,237 | $13K | |
| 87186 | <1% | 3,078 | $12K | |
| 82550 | <1% | 3,234 | $11K | |
| 85379 | <1% | 1,855 | $11K | |
| 73110 | <1% | 815 | $11K | |
| J1815 | Injection, insulin, per 5 units | <1% | 476 | $10K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 652 | $10K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,751 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 30,662 | $10K |
| 0272 | <1% | 4,129 | $10K | |
| 70486 | <1% | 124 | $9K | |
| 59025 | Fetal non-stress test | <1% | 1,233 | $9K |
| 72131 | <1% | 128 | $9K | |
| 84439 | <1% | 3,315 | $8K | |
| 96376 | <1% | 1,044 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,905 | $7K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,743 | $7K |
| 0710 | <1% | 1,544 | $7K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 587 | $7K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,112 | $7K |
| 72100 | <1% | 412 | $7K | |
| 87276 | <1% | 1,698 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 170 | $6K |
| 93798 | <1% | 262 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,114 | $6K |
| A4649 | Surgical supply; miscellaneous | <1% | 1,855 | $6K |
| 99070 | <1% | 1,696 | $6K | |
| 80051 | <1% | 1,712 | $6K | |
| 73590 | <1% | 430 | $6K | |
| 84703 | <1% | 1,925 | $5K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,078 | $5K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 2,172 | $5K |
| 87275 | <1% | 1,698 | $5K | |
| 71250 | <1% | 100 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,002 | $5K |
| 73562 | <1% | 349 | $5K | |
| 97116 | <1% | 505 | $5K | |
| 86900 | <1% | 3,480 | $5K | |
| 76801 | <1% | 224 | $4K | |
| 86850 | <1% | 1,923 | $4K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 186 | $4K |
| 99499 | <1% | 312 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,653 | $4K |
| 87070 | <1% | 2,090 | $4K | |
| 73502 | <1% | 246 | $4K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 198 | $4K |
| 80061 | Lipid panel | <1% | 7,080 | $4K |
| 0121 | <1% | 105 | $4K | |
| 0760 | <1% | 6,905 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 686 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 29 | $3K |
| 73080 | <1% | 187 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 460 | $3K |
| 97139 | <1% | 419 | $3K | |
| 96367 | <1% | 112 | $3K | |
| 87084 | <1% | 727 | $3K | |
| 0278 | <1% | 282 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 986 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,680 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,947 | $3K |
| 82962 | <1% | 2,619 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 529 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 133 | $3K |
| 73090 | <1% | 217 | $3K | |
| 87430 | <1% | 516 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,170 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 453 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 57 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 450 | $2K |
| 70491 | <1% | 13 | $2K | |
| 76870 | <1% | 79 | $2K | |
| 85018 | <1% | 1,725 | $2K | |
| 74018 | <1% | 188 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 303 | $2K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 132 | $2K |
| 86140 | <1% | 1,129 | $2K | |
| 71101 | <1% | 87 | $2K | |
| 82553 | <1% | 210 | $1K | |
| 0324 | <1% | 505 | $1K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 855 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 37 | $1K |
| 99153 | Mod sedat endo service >5yrs | <1% | 381 | $1K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 55 | $1K |
| 76641 | <1% | 114 | $976.67 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 27 | $971.60 |
| 0370 | <1% | 904 | $960.76 | |
| Z7610 | <1% | 258 | $930.78 | |
| 76642 | <1% | 103 | $904.27 | |
| 85652 | <1% | 1,450 | $876.14 | |
| 87205 | <1% | 568 | $852.61 | |
| A9270 | Non-covered item or service | <1% | 1,078 | $797.38 |
| 71010 | <1% | 51 | $767.46 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 107 | $744.22 |
| 88313 | <1% | 299 | $698.55 | |
| 86703 | <1% | 1,080 | $689.32 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 115 | $668.97 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 43 | $642.72 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,850 | $606.97 |
| 86901 | <1% | 491 | $592.68 | |
| 87420 | <1% | 284 | $586.62 | |
| 81000 | <1% | 409 | $584.32 | |
| 82607 | <1% | 914 | $580.37 | |
| 0636 | <1% | 2,357 | $566.05 | |
| 99152 | <1% | 27 | $554.82 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 223 | $552.12 |
| 97799 | <1% | 105 | $551.22 | |
| 82043 | <1% | 1,641 | $518.63 | |
| 12001 | <1% | 50 | $511.72 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 37 | $509.27 |
| 86592 | <1% | 1,342 | $488.19 | |
| 80076 | <1% | 122 | $467.06 | |
| 0420 | <1% | 140 | $451.28 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 142 | $402.80 |
| 82728 | <1% | 657 | $398.35 | |
| 73060 | <1% | 30 | $376.16 | |
| 72110 | <1% | 37 | $362.34 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 84 | $350.08 |
| 82746 | <1% | 486 | $335.99 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 701 | $300.24 |
| 88312 | <1% | 252 | $271.25 | |
| 80074 | <1% | 71 | $242.81 | |
| 87081 | <1% | 544 | $242.02 | |
| 73120 | <1% | 24 | $224.82 | |
| 29125 | <1% | 65 | $223.67 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 68 | $222.00 |
| 83540 | <1% | 529 | $217.59 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 18 | $207.89 |
| 73620 | <1% | 24 | $206.76 | |
| 84100 | <1% | 135 | $186.32 | |
| 82140 | <1% | 42 | $181.85 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 19 | $168.53 |
| 77066 | Tomosynthesis, mammo | <1% | 26 | $164.27 |
| 94664 | <1% | 13 | $155.92 | |
| 82010 | <1% | 36 | $145.70 | |
| 88304 | <1% | 67 | $141.28 | |
| 87210 | <1% | 55 | $141.12 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 13 | $133.71 |
| 84550 | <1% | 617 | $127.00 | |
| 84153 | <1% | 571 | $124.32 | |
| 73560 | <1% | 12 | $124.09 | |
| 73140 | <1% | 12 | $115.46 | |
| 83550 | <1% | 505 | $109.96 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 14 | $101.34 |
| 0258 | <1% | 399 | $100.10 | |
| 0300 | <1% | 2,333 | $95.66 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 112 | $82.50 |
| 20610 | <1% | 16 | $70.70 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 56 | $61.24 |
| 87807 | <1% | 12 | $59.91 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 27 | $58.26 |
| 0730 | <1% | 342 | $49.60 | |
| 0307 | <1% | 993 | $48.41 | |
| 87339 | <1% | 95 | $44.97 | |
| 82731 | <1% | 13 | $44.95 | |
| 87340 | <1% | 172 | $40.32 | |
| 86803 | <1% | 123 | $39.26 | |
| 96127 | <1% | 73 | $38.48 | |
| 82570 | <1% | 82 | $34.23 | |
| 87481 | <1% | 173 | $32.64 | |
| 0305 | <1% | 1,741 | $27.00 | |
| 86038 | <1% | 57 | $21.75 | |
| 90677 | <1% | 91 | $9.00 | |
| 90681 | <1% | 16 | $9.00 | |
| 82270 | <1% | 189 | $6.28 | |
| 84436 | <1% | 197 | $5.33 | |
| 77080 | <1% | 57 | $5.11 | |
| 83655 | <1% | 84 | $5.00 | |
| 94150 | <1% | 39 | $4.79 | |
| 86225 | <1% | 29 | $2.52 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 51 | $0.00 |
| 0306 | 0% | 1,228 | $0.00 | |
| 90723 | 0% | 44 | $0.00 | |
| 84480 | 0% | 216 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 2,123 | $0.00 |
| 0352 | 0% | 98 | $0.00 | |
| 90697 | 0% | 53 | $0.00 | |
| 0471 | 0% | 33 | $0.00 | |
| 0720 | 0% | 26 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 13 | $0.00 |
| 90686 | 0% | 72 | $0.00 | |
| 0310 | 0% | 27 | $0.00 | |
| 86706 | 0% | 122 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 73 | $0.00 |
| 0214 | 0% | 70 | $0.00 | |
| 90656 | 0% | 13 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 836 | $0.00 |
| 0320 | 0% | 42 | $0.00 | |
| 0390 | 0% | 1,353 | $0.00 | |
| 0302 | 0% | 1,073 | $0.00 | |
| 0460 | 0% | 182 | $0.00 | |
| 96160 | 0% | 127 | $0.00 | |
| 90461 | 0% | 507 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 13 | $0.00 |
| 99173 | 0% | 26 | $0.00 | |
| 0402 | 0% | 150 | $0.00 | |
| 0424 | 0% | 13 | $0.00 | |
| 90670 | 0% | 173 | $0.00 | |
| 90633 | 0% | 26 | $0.00 | |
| 90671 | 0% | 26 | $0.00 | |
| 90648 | 0% | 61 | $0.00 | |
| 0483 | 0% | 13 | $0.00 | |
| 77062 | 0% | 13 | $0.00 | |
| 84112 | 0% | 17 | $0.00 | |
| 0312 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARMA, ROGER (EXECUTIVE VP/CFO)
Parent organizationEMANATE HEALTH
| Provider | Location | Paid |
|---|---|---|
| Emanate Health Medical Center | West Covina, CA | $23.44M |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | $9.78M |
| Emanate Health Medical Center | Covina, CA | $163K |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | $81K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.